Aristotle Capital Boston, LLC Albemarle Corp Transaction History

Aristotle Capital Boston, LLC

$2.93 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$208.49 - $290.15 $433,033 - $602,641	2,077 Added 8.74%	25,836 $5.71 Million
Q4 2022 Feb 14, 2023	SELL	$214.02 - $325.38 $190,049 - $288,937	-888 Reduced 3.6%	23,759 $5.15 Million
Q3 2022 Nov 14, 2022	SELL	$195.82 - $307.05 $3.13 Million - $4.91 Million	-16,002 Reduced 39.37%	24,647 $6.52 Million
Q2 2022 Aug 15, 2022	SELL	$187.76 - $270.92 $427,905 - $617,426	-2,279 Reduced 5.31%	40,649 $8.5 Million
Q1 2022 May 16, 2022	SELL	$172.09 - $246.0 $3,958 - $5,658	-23 Reduced 0.05%	42,928 $9.49 Million
Q4 2021 Feb 14, 2022	SELL	$214.16 - $283.8 $488,284 - $647,064	-2,280 Reduced 5.04%	42,951 $10 Million
Q3 2021 Nov 15, 2021	SELL	$167.91 - $244.03 $2.32 Million - $3.37 Million	-13,813 Reduced 23.39%	45,231 $9.9 Million
Q2 2021 Aug 16, 2021	SELL	$143.7 - $176.01 $196,725 - $240,957	-1,369 Reduced 2.27%	59,044 $9.95 Million
Q1 2021 May 17, 2021	SELL	$140.69 - $185.25 $2.3 Million - $3.03 Million	-16,371 Reduced 21.32%	60,413 $8.83 Million
Q4 2020 Feb 22, 2021	BUY	$86.73 - $149.91 $128,360 - $221,866	1,480 Added 1.97%	76,784 $11.3 Million
Q4 2020 Feb 16, 2021	SELL	$86.73 - $149.91 $75,194 - $129,971	-867 Reduced 1.14%	75,304 $11.1 Million
Q3 2020 Nov 16, 2020	SELL	$75.75 - $100.45 $1.99 Million - $2.64 Million	-26,237 Reduced 25.62%	76,171 $6.8 Million
Q2 2020 Aug 14, 2020	SELL	$52.7 - $86.74 $1.03 Million - $1.7 Million	-19,605 Reduced 16.07%	102,408 $7.91 Million
Q1 2020 May 15, 2020	SELL	$50.9 - $94.31 $6.38 Million - $11.8 Million	-125,317 Reduced 50.67%	122,013 $6.88 Million
Q4 2019 Feb 14, 2020	SELL	$60.74 - $73.04 $561,905 - $675,693	-9,251 Reduced 3.61%	247,330 $18.1 Million
Q3 2019 Nov 14, 2019	BUY	$59.3 - $75.53 $2.66 Million - $3.39 Million	44,937 Added 21.23%	256,581 $17.8 Million
Q2 2019 Mar 04, 2020	BUY	$63.3 - $86.94 $9.99 Million - $13.7 Million	157,856 Added 293.48%	211,644 $14.9 Million
Q2 2019 Aug 14, 2019	SELL	$63.3 - $86.94 $8.42 Million - $11.6 Million	-133,056 Reduced 71.21%	53,788 $3.79 Million
Q1 2019 Mar 04, 2020	BUY	$72.69 - $92.28 $10.3 Million - $13 Million	141,089 Added 308.36%	186,844 $15.3 Million
Q1 2019 May 15, 2019	BUY	$72.69 - $92.28 $143,271 - $181,883	1,971 Added 4.5%	45,755 $3.75 Million
Q4 2018 Feb 13, 2019	BUY	$73.13 - $107.99 $703,510 - $1.04 Million	9,620 Added 28.16%	43,784 $3.37 Million
Q3 2018 Sep 16, 2019	BUY	$90.9 - $106.6 $23,997 - $28,142	264 Added 0.78%	34,164 $3.41 Million
Q3 2018 Nov 14, 2018	BUY	$90.9 - $106.6 $481,860 - $565,086	5,301 Added 18.54%	33,900 $3.38 Million
Q2 2018 Aug 13, 2018	SELL	$88.96 - $104.92 $9.64 Million - $11.4 Million	-108,344 Reduced 79.12%	28,599 $2.7 Million
Q1 2018 May 15, 2018	BUY	$89.56 - $137.45 $6.33 Million - $9.71 Million	70,646 Added 106.56%	136,943 $12.7 Million
Q4 2017 Feb 14, 2018	BUY	$127.48 - $144.58 $2.58 Million - $2.93 Million	20,243 Added 43.95%	66,297 $8.48 Million
Q3 2017 Nov 14, 2017	BUY	$109.36 - $136.31 $5.04 Million - $6.28 Million	46,054	46,054 $6.28 Million

Others Institutions Holding ALB

# of Institutions

928

Shares Held

104M

Call Options Held

8.36M

Put Options Held

14.3M

Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$1.53 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

9.96M
Shares

$1.07 Billion
0.02% of portfolio
State Street Corp Boston, MA

6.56M
Shares

$706 Million
0.03% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$689 Million
0.1% of portfolio
Primecap Management CO Pasadena, CA

3.83M
Shares

$413 Million
0.27% of portfolio

View Full List

About ALBEMARLE CORP

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.6B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

More about ALB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Boston, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Boston, LLC with notifications on news.

Account